Showing 1 - 10 of 10
The enforcement of stringent intellectual property rights in the pharmaceutical sector of developing countries generates considerable controversy, due to both the extensive research investment and the public policy importance of this sector. This paper explores the likely effects of enforcing...
Persistent link: https://www.econbiz.de/10011395349
Persistent link: https://www.econbiz.de/10010414865
Persistent link: https://www.econbiz.de/10010423401
Persistent link: https://www.econbiz.de/10009562852
Persistent link: https://www.econbiz.de/10011436798
In 2005, as the result of a World Trade Organization mandate, India implemented a patent reform for pharmaceuticals that was intended to comply with the 1995 Trade-Related Aspects of Intellectual Property Rights (TRIPS). Exploiting variation in the timing of patent decisions, we estimate that a...
Persistent link: https://www.econbiz.de/10012702784
The enforcement of stringent intellectual property rights in the pharmaceutical sector of developing countries generates considerable controversy, due to both the extensive research investment and the public policy importance of this sector. This paper explores the likely effects of enforcing...
Persistent link: https://www.econbiz.de/10012554495
The enforcement of stringent intellectual property rights in the pharmaceutical sector of developing countries generates considerable controversy, due to both the extensive research investment and the public policy importance of this sector. This paper explores the likely effects of enforcing...
Persistent link: https://www.econbiz.de/10012975244
In 2005, as the result of a World Trade Organization mandate, India began to implement product patents for pharmaceuticals that were compliant with the 1995 Trade-Related Aspects of Intellectual Property Rights (TRIPS). We combine pharmaceutical product sales data for India with a newly gathered...
Persistent link: https://www.econbiz.de/10013046165
In 2005, as the result of a World Trade Organization mandate, India began to implement product patents for pharmaceuticals that were compliant with the 1995 Trade-Related Aspects of Intellectual Property Rights (TRIPS). We combine pharmaceutical product sales data for India with a newly gathered...
Persistent link: https://www.econbiz.de/10012458117